Classification Criteria for Multifocal Choroiditis With Panuveitis.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
08 2021
Historique:
received: 10 07 2020
revised: 29 01 2021
accepted: 31 03 2021
pubmed: 13 4 2021
medline: 16 11 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

To determine classification criteria for multifocal choroiditis with panuveitis (MFCPU). Machine learning of cases with MFCPU and 8 other posterior uveitides. Cases of posterior uveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the posterior uveitides. The resulting criteria were evaluated on the validation set. One thousand sixty-eight cases of posterior uveitides, including 138 cases of MFCPU, were evaluated by machine learning. Key criteria for MFCPU included (1) multifocal choroiditis with the predominant lesions size >125 µm in diameter; (2) lesions outside the posterior pole (with or without posterior involvement); and either (3) punched-out atrophic chorioretinal scars or (4) more than minimal mild anterior chamber and/or vitreous inflammation. Overall accuracy for posterior uveitides was 93.9% in the training set and 98.0% (95% confidence interval 94.3, 99.3) in the validation set. The misclassification rates for MFCPU were 15% in the training set and 0% in the validation set. The criteria for MFCPU had a reasonably low misclassification rate and seemed to perform sufficiently well for use in clinical and translational research.

Identifiants

pubmed: 33845016
pii: S0002-9394(21)00168-9
doi: 10.1016/j.ajo.2021.03.043
pmc: PMC8559518
mid: NIHMS1694765
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-158

Subventions

Organisme : NEI NIH HHS
ID : R01 EY026593
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Retina. 2002 Oct;22(5):545-9
pubmed: 12441718
Arch Ophthalmol. 2010 Jan;128(1):46-56
pubmed: 20065216
Acta Ophthalmol Scand. 2004 Dec;82(6):748-53
pubmed: 15606476
J Ophthalmic Inflamm Infect. 2018 Sep 12;8(1):13
pubmed: 30209691
JAMA Ophthalmol. 2013 Jun;131(6):787-9
pubmed: 23764704
Ophthalmology. 1996 Jul;103(7):1100-5
pubmed: 8684800
Ocul Immunol Inflamm. 2011 Dec;19(6):426-30
pubmed: 22106911
J Ophthalmic Vis Res. 2016 Oct-Dec;11(4):429-432
pubmed: 27994812
Retina. 2007 Nov-Dec;27(9):1174-9
pubmed: 18046221
Am J Ophthalmol. 2018 Feb;186:19-24
pubmed: 29122577
Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3573-81
pubmed: 21357402
Jpn J Ophthalmol. 2008 Jul-Aug;52(4):282-288
pubmed: 18773266
Clin Ophthalmol. 2014 Sep 29;8:2001-12
pubmed: 25302012
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Retina. 2013 Jul-Aug;33(7):1315-24
pubmed: 23584703
Am J Ophthalmol. 2020 May;213:244-251
pubmed: 32027868
Ocul Immunol Inflamm. 2017;25(sup1):S107-S114
pubmed: 27901620
Ophthalmology. 1996 Dec;103(12):2061-9
pubmed: 9003340
Ann Ophthalmol. 1991 Nov;23(11):424-9
pubmed: 1776772
Methods Inf Med. 2013;52(3):259-65, S1-6
pubmed: 23392263
Am J Ophthalmol. 2013 Aug;156(2):228-36
pubmed: 23668682
Ophthalmology. 2018 Feb;125(2):193-202
pubmed: 28942074
Ophthalmology. 2002 Feb;109(2):378-83
pubmed: 11825826
Arch Ophthalmol. 1984 Dec;102(12):1776-84
pubmed: 6508619
Am J Ophthalmol. 2007 Apr;143(4):721-3
pubmed: 17386295
Int J Retina Vitreous. 2017 Mar 20;3:12
pubmed: 28331634
Arthritis Care Res (Hoboken). 2015 Jul;67(7):891-7
pubmed: 25776731
Acta Ophthalmol. 2013 Sep;91(6):492-7
pubmed: 22863241
Retina. 2013 Jan;33(1):1-4
pubmed: 23026849
Am J Ophthalmol. 2021 Aug;228:275-280
pubmed: 33845011
Am J Ophthalmol. 1984 Nov;98(5):572-84
pubmed: 6208783
Ophthalmology. 2006 Dec;113(12):2310-6
pubmed: 16996607

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH